Related references
Note: Only part of the references are listed.Reduced brain-derived neurotrophic factor is associated with childhood trauma experiences and number of depressive episodes in severe mental disorders
Monica Aas et al.
SCHIZOPHRENIA RESEARCH (2019)
Neuroinflammation and cognition across psychiatric conditions
Celia Fourrier et al.
CNS SPECTRUMS (2019)
The emerging role of exosomes in mental disorders
Saumeh Saeedi et al.
TRANSLATIONAL PSYCHIATRY (2019)
Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia
Lijuan Man et al.
PSYCHIATRY RESEARCH (2018)
Cognitive deficit in patients with paranoid schizophrenia: Its clinical and laboratory correlates
Mariia Dorofeikova et al.
PSYCHIATRY RESEARCH (2018)
Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
Norbert Mueller
SCHIZOPHRENIA BULLETIN (2018)
Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia
Leticia Gonzalez-Blanco et al.
PSYCHIATRY RESEARCH (2018)
Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review
Blazej Misiak et al.
SCHIZOPHRENIA RESEARCH (2018)
Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
Yoshie Omachi et al.
FRONTIERS IN PSYCHIATRY (2018)
C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
Guillaume Fond et al.
FRONTIERS IN PSYCHIATRY (2018)
C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls
Isabella Jacomb et al.
FRONTIERS IN IMMUNOLOGY (2018)
C-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia
Ted Boozalis et al.
FRONTIERS IN PUBLIC HEALTH (2018)
The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis
E. Bora et al.
PSYCHOLOGICAL MEDICINE (2017)
Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy
Hikaru Hori et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2017)
Cognitive impairment in first-episode drug-naive patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor
Wenhuan Xiao et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis
E. Bora et al.
PSYCHOLOGICAL MEDICINE (2017)
Developmental Differences Between Schizophrenia and Bipolar Disorder
Mara Parellada et al.
SCHIZOPHRENIA BULLETIN (2017)
BDNF Val66Met polymorphism modulates the effect of loneliness on white matter microstructure in young adults
Jie Meng et al.
BIOLOGICAL PSYCHOLOGY (2017)
C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
B. S. Fernandes et al.
MOLECULAR PSYCHIATRY (2016)
The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis
Erik Johnsen et al.
BMC PSYCHIATRY (2016)
Impact of Cognitive and Social Cognitive Impairment on Functional Outcomes in Patients With Schizophrenia
Michael F. Green
JOURNAL OF CLINICAL PSYCHIATRY (2016)
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
D. R. Goldsmith et al.
MOLECULAR PSYCHIATRY (2016)
Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset
Ewa Bulzacka et al.
SCHIZOPHRENIA BULLETIN (2016)
Cognitive Impairment in Schizophrenia: Interplay of BDNF and Childhood Trauma? A Review of Literature
Geetanjali Sahu et al.
PSYCHIATRIC QUARTERLY (2016)
Regulation of hippocampal synaptic plasticity by BDNF
Graciano Leal et al.
BRAIN RESEARCH (2015)
Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: A meta-analysis
Anthony O. Ahmed et al.
PSYCHIATRY RESEARCH (2015)
Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls
Emre Bora et al.
SCHIZOPHRENIA BULLETIN (2015)
Neuroinflammation and white matter pathology in schizophrenia: systematic review
Souhel Najjar et al.
SCHIZOPHRENIA RESEARCH (2015)
Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia
Jean-Arthur t Micoulaud-Franchi et al.
SCHIZOPHRENIA RESEARCH (2015)
Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups
Jamie Joseph et al.
SCHIZOPHRENIA RESEARCH (2015)
Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications
B. S. Fernandes et al.
MOLECULAR PSYCHIATRY (2015)
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Golam M. Khandaker et al.
LANCET PSYCHIATRY (2015)
Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis
E. Bora et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
Inflammatory mediators of cognitive impairment in bipolar disorder
Isabelle E. Bauer et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia
Tomihisa Niitsu et al.
NEUROSCIENCE LETTERS (2014)
Meta-analysis of Cognitive Deficits in Ultra-high Risk to Psychosis and First-Episode Psychosis: Do the Cognitive Deficits Progress Over, or After, the Onset of Psychosis?
Emre Bora et al.
SCHIZOPHRENIA BULLETIN (2014)
Brain derived neurotropic factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis
Christos Theleritis et al.
SCHIZOPHRENIA RESEARCH (2014)
Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis
Sonia Ruiz de Azua et al.
BMC PSYCHIATRY (2013)
Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia
Elson Asevedo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
The Interplay of Stress and Sleep Impacts BDNF Level
Maria Giese et al.
PLOS ONE (2013)
Comorbid substance use disorder in schizophrenia: A selective overview of neurobiological and cognitive underpinnings
Patrizia Thoma et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2013)
Inflammation and Schizophrenia
Brian Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2013)
Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: A meta-analysis
Amber De Herdt et al.
SCHIZOPHRENIA RESEARCH (2013)
The global cognitive impairment in schizophrenia: Consistent over decades and around the world
Jonathan Schaefer et al.
SCHIZOPHRENIA RESEARCH (2013)
Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: A quantitative and qualitative review
Jessica Agnew-Blais et al.
COGNITIVE NEUROPSYCHIATRY (2013)
Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia
Xiang Yang Zhang et al.
PSYCHOPHARMACOLOGY (2012)
Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia
Faith Dickerson et al.
SCHIZOPHRENIA RESEARCH (2012)
Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia
Davide Carlino et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
BDNF gene effects on brain circuitry replicated in 455 twins
Ming-Chang Chiang et al.
NEUROIMAGE (2011)
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis
Anne-Kathrin J. Fett et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia
Tomihisa Niitsu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Childhood trauma and cognitive function in first-episode affective and non-affective psychosis
Monica Aas et al.
SCHIZOPHRENIA RESEARCH (2011)
Cognitive Impairment in Schizophrenia and Affective Psychoses: Implications for DSM-V Criteria and Beyond
Emre Bora et al.
SCHIZOPHRENIA BULLETIN (2010)
Is Serum Brain-Derived Neurotrophic Factor a Biomarker for Cognitive Enhancement in Schizophrenia?
Sophia Vinogradov et al.
BIOLOGICAL PSYCHIATRY (2009)
Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia
Naoki Goto et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
TrkB signalling pathways in LTP and learning
Liliana Minichiello
NATURE REVIEWS NEUROSCIENCE (2009)
Neurocognition in First-Episode Schizophrenia: A Meta-Analytic Review
Raquelle I. Mesholam-Gately et al.
NEUROPSYCHOLOGY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Contradictory cognitive capacities among substance-abusing patients with schizophrenia: A meta-analysis
Stephane Potvin et al.
SCHIZOPHRENIA RESEARCH (2008)
Share Paper
